
Opinion|Videos|May 15, 2024
Payer Needs and Strategies for Evaluating and Covering PDTs
Panelists delve into the data and the cost-saving evidence required by payers to cover prescription digital therapeutics (PDTs), outline the decision-making process followed by payers, and share best practices observed in real-world to ensure the successful implementation of PDTs.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment
2
Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations
3
New Dermatologic Therapies Make Waves at Maui Derm 2026
4
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
5








